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Abstract 
Background: Clinical significance of small airway obstruction in mild pediatric asthma is unclear. 
Objective: To evaluate small airway properties in children with mild-tomoderate asthmatic 
symptoms, and the association of small airway function with asthma control and exercise-induced 
bronchoconstriction (EIB). Methods: Children (5-10 years) with either recurrent wheezing (n=42) 
or persistent troublesome cough (n=16), and healthy controls (n=19) performed impulse 
oscillometry (IOS), spirometry, and multiple-breath nitrogen washout (MBNW) test. Exhaled nitric 
oxide (NO) was measured at multiple flow rates to determine alveolar NO concentration (CALV). 
Asthma control was evaluated with the Childhood Asthma Control Test (C-ACT), short-acting 
beta2-agonist (SABA) use within the past month, and asthma exacerbations within the past year. 
Results: IOS, spirometry, and exhaled NO indices which are related to small airway function 
differed between children with recurrent wheezing and healthy controls, whereas only forced 
expiratory flow at 25-75% of the forced vital capacity (FEF25-75) was associated with persistent 
cough. MBNW indices showed no difference between the groups. Among symptomatic children, 
conducting airway ventilation inhomogeneity (Scond) and CALV were associated with asthma 
exacerbations (p=0.028 and p=0.002, respectively), and lung clearance index (LCI) and CALV 
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were associated with EIB (p=0.044 and p=0.004, respectively). None of the proposed small airway 
indices was associated with the C-ACT score or SABA use. Conclusion: Subtle changes were 
observed in the proposed small airway indices of IOS, spirometry, and exhaled NO among children 
with mild-tomoderate recurrent wheezing. Small airway dysfunction, expressed as ventilation 
inhomogeneity indices and CALV, was also associated with asthma exacerbations and EIB. 
 
Keywords 
pediatric asthma, early wheezing, small airways, lung function testing, impulse oscillometry, 
spirometry, multiple-breath washout, exhaled nitric oxide, asthma control, bronchial 
hyperresponsiveness 
 
Abbreviations: AUC, area under receiver operating characteristic curve; AX, area under the 
reactance curve; CALV, alveolar nitric oxide concentration; CI, confidence interval; C-ACT, 
childhood asthma control test; EIB, exercise-induced bronchoconstriction; FEF25-75, forced 
expiratory flow between 25% and 75% of the forced vital capacity; FENO, fractional exhaled nitric 
oxide; FENO50, FENO at 50 ml/s; FEV1, forced expiratory volume in 1 second; FRC, functional 
residual capacity; FVC, forced vital capacity; IOS, impulse oscillometry; IQR, interquartile range; 
JNO, bronchial nitric oxide flux; LCI, lung clearance index; MBNW, multiple-breath nitrogen 
washout; MBW, multiple-breath washout; NO, nitric oxide; r
2
, goodness of fit; R5, respiratory 
resistance at 5 Hz; R20, respiratory resistance at 20 Hz; R5-20, difference between respiratory 
resistance at 5 and 20 Hz; ROC, receiver operating characteristics; SABA, short-acting beta2-
agonist; Sacin, ventilation inhomogeneity in the acinar structures; Scond, ventilation inhomogeneity 
in the conducting airways; X5, respiratory reactance at 5 Hz. 
INTRODUCTION 
Bronchial biopsies and post-mortem studies have demonstrated the involvement of small airway 
inflammation in asthma,
1,2
 supported by clinical studies on the association between small airway 
dysfunction and clinical expression of asthma.
3,4
 In children, abnormalities in the proposed small 
airway indices have been related to uncontrolled or severe asthma,
5-7
 but their potential to 
distinguish milder disease changes remains debated.
8,9
 It is plausible to hypothesize small airways 
to be involved to some extent in most patients with asthma,
10
 even in children. Early involvement of 
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small airways has also been recognized as a risk factor for future chronic obstructive pulmonary 
disease.
11
 Furthermore, with the emergence of small-particle aerosols that reach the lung periphery, 
accurate measures for small airways are necessitated to identify and follow patients who might 
benefit from this treatment. However, conventional lung function measures, such as forced 
expiratory volume in 1 second (FEV1), mainly reflect large airways, and no gold standard measures 
for small airways exist. Potential methods for assessing small airway properties include impulse 
oscillometry (IOS), spirometry, multiple-breath washout (MBW) tests, and extended exhaled nitric 
oxide (NO) analysis. 
IOS measures respiratory resistance and reactance by analyzing responses to pulse signals of 
different frequencies. High frequency resistance values, such as resistance at 20 Hz (R20), are 
considered to reflect large airway resistive properties, whereas lower frequencies, such as resistance 
at 5 Hz (R5), reflect the whole respiratory system.
12
 Small airway obstruction is thought to result in 
frequency-dependence of resistance, and thus increased difference between R5 and R20 (R5-20).
5
 
Negative reactance values reflect the capacitative properties of the lung periphery, and thus 
reactance at 5 Hz (X5) and area under the reactance curve (AX) are considered to reflect small 
airway function.
5,12
  
During forced expiration, small airway obstruction is postulated to contribute to airflow limitation 
during the mid- and end-phases of the forced vital capacity (FVC). This results in diminished mid-
expiratory flow rates, without significant effects on FEV1 which mainly reflects large airway 
function at the initial part of forced expiration.
13
 Mid-expiratory flow rates can be evaluated by 
calculating the forced expiratory flow between 25% and 75% of the FVC (FEF25-75), which is 
considered to reflect the medium- and small airway function. 
MBW measures ventilation distribution homogeneity by analyzing the washout pattern of an inert 
marker gas. Lung clearance index (LCI) is postulated to reflect the overall ventilation 
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inhomogeneity secondary to small airway disease.
14
 The washout pattern over several breaths aims 
to separate convection-dependent ventilation inhomogeneity in the small conducting airways 
(Scond) and diffusion-convection-dependent inhomogeneity in the acinar structures (Sacin).
14
  
Airway inflammation enhances production of NO in the bronchial epithelium.
15
 At low flow rates, 
such as 50 ml/s, the fractional exhaled NO (FENO) mainly reflects NO from the central airways.
16
 
With increasing flow rates, contribution of proximal airways decreases and FENO represents 
alveolar NO.
16
 Applications with multiple exhalation flow rates have been created to separate 
alveolar NO concentration (CALV) from bronchial NO flux (JNO).
15
  
Our primary aim was to investigate whether small airway dysfunction is present in young children 
with mild-to-moderate asthmatic symptoms by using different indicators of small airway 
involvement: IOS, spirometry, multiple-breath nitrogen washout (MBNW) test, and extended FENO 
measurement. The secondary aim was to evaluate the association of these measurements with 
asthma control and exercise-induced bronchoconstriction (EIB). Finally, considering their proposed 
relationship with small airway function, we hypothesized that the small airway indices of the 
compared methods would be associated with each other.  
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METHODS 
Subjects 
The symptomatic children (n=58) aged 5-10 years were recruited from patients that were referred to 
a tertiary unit between April 2016 and May 2017 due to symptoms indicating probable asthma. 
Inclusion criteria were: 1) symptoms indicating probable asthma: ≥3 episodes of wheezing, or 
troublesome cough lasting continuously for ≥6 weeks without indications of alternative differential 
diagnoses, 2) no other chronic or acute diseases of the respiratory system, and 3) acceptable lung 
function measurements at the first visit. At the first visit, the children first performed IOS and then 
spirometry measurements, combined with an exercise challenge test. MBNW and extended FENO 
measurements were performed at the second visit within 14 days. The parents of 65 symptomatic 
children delivered an informed consent for study participation. Thereafter, 4 children were excluded 
due to symptoms of a respiratory tract infection before the second visit, 2 children because of 
failure to deliver the research questionnaires, and 1 child later refused blood sampling.  
Nineteen healthy controls aged 5-10 years were recruited through an announcement which was 
targeted to the personnel of the hospital from which the patient were recruited. Inclusion criteria 
were: 1) no symptoms or diagnosis of acute or chronic respiratory disease, and 2) no systemic 
disease with possible direct or indirect respiratory effects. All of the healthy controls who filled the 
inclusion criteria performed successful IOS and spirometry measurements and were included in the 
study. Healthy children performed MBNW, extended FENO, IOS, and spirometry measurements in 
the aforementioned order during one visit. 
All children were free from respiratory tract infections for at least 2 weeks, and possible asthma-
control medications ceased at least 4 weeks prior to the lung function measurements according to 
national practice guidelines. This was done to minimize their possible confounding effect on lung 
function. Parents filled a questionnaire on the child’s family history, health status, and symptoms. 
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Asthma control was evaluated with the Childhood Asthma Control Test (C-ACT) (a score of ≤19 
indicated inadequate asthma control
17
), use of short-acting beta2-agonist (SABA) within the past 
month, and asthma exacerbations (episodes of shortness of breath or wheezing) within the past year. 
Impulse oscillometry 
IOS (Masterscreen IOS, Carefusion, Hoechberg, Germany) measurements were performed as 
described earlier,
18
 according to international recommendations.
19
 During all lung function 
measurements, the children were in a sitting position and breathed through a mouthpiece using a 
nose clip. To minimize pressure losses in IOS, cheeks were supported by the investigator. The 
measurement was accepted when ≥3 regular tidal breathing patterns lasting ≥20 seconds without 
signs of artefacts, such as apnea, speaking, swallowing, or air leak were obtained. Table 1 
summarizes the postulated small airway indices of the different measurements used in the study and 
their hypothetical physiological determinants. 
Spirometry 
Spirometry (Masterscreen Pneumo, Carefusion, Hoechberg, Germany) was performed according to 
international guidelines,
20
 with ≥3 successful measurements recorded, and the highest values of 
FEV1 and FVC used in the analyses. Flow indices were derived from the curve with the largest sum 
of FEV1 and FVC. During the measurement, the investigator inspected the volume-time and flow-
volume tracings and excluded unacceptable measurements. 
Multiple-breath nitrogen washout 
MBNW (Exhalyzer D, Ecomedics, Duernten, Switzerland) was performed according to 
international guidelines,
14
 by analyzing the washout pattern of endogenous nitrogen during tidal 
breathing of 100% oxygen. During the measurement, the investigator monitored the tracings of tidal 
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volume and marker gas concentrations, and rejected measurements with signs of inert gas leaks. A 
minimum of 2 successful recordings were required, and mean values were used in the analyses. 
Extended exhaled nitric oxide 
FENO was measured with a chemiluminescence analyzer (CLD 88, Ecomedics, Duernten, 
Switzerland) at four different flow rates: 30, 50, 100, and 200 ml/s, with ≥2 successful 
measurements required for each flow rate. FENO was determined at 50 ml/s (FENO50) according to 
international recommendations.
21
 Two-compartment linear model
22
 with three flow rates: 100, 200, 
and either 30 or 50 ml/s for achieving the best goodness of fit (r
2
), was used to calculate JNO and 
CALV. 
Exercise-induced bronchoconstriction 
The symptomatic children performed an outdoor free-running test with either IOS or spirometry as 
described earlier.
23
 EIB was defined as an increase of ≥35% in R523 or a decrease of ≥15% in 
FEV1
24
 at 1, 5, or 10 minutes after the exercise. 
Eosinophilia and atopy 
Eosinophilia was defined as peripheral blood eosinophil count of ≥0.4*109/L and eosinophils 
composing ≥4% of leukocytes. Atopy was defined as serum-specific IgE level of ≥0.35 kU/l or skin 
prick test wheal diameter of ≥3 mm to ≥1 inhaled aeroallergens: birch, timothy grass, meadow 
fescue, mugwort, Cladosporium herbarum, cat, dog, horse, cow, and Dermatophagoides 
pteronyssinus. Histamine dihydrochloride (10 mg/ml, ALK) served as a positive and physiologic 
saline as a negative control in the skin prick tests. 
Statistical analyses 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 8 
Power calculations were performed prior to the study for 80% power and 0.05 type I error, with the 
assumption that the mean AX (standard deviation 0.87 kPa/L)
25
 in symptomatic children would 
differ 0.5 kPa/L from healthy controls, and a 20% margin for possible unsuccessful measurements 
was used. Accordingly, 58 symptomatic children were recruited. 
Due to the lack of applicable reference values that would encompass the age range and nationality 
of the study children, the data were analyzed with height- and sex-adjusted regression analyses. 
Normality of the variables was evaluated with Kolmogorov-Smirnov or Shapiro-Wilk test. 
Comparisons between groups were performed with Mann-Whitney U test or with logistic regression 
analyses that were adjusted for relevant baseline factors. Receiver operating characteristics (ROC) 
curves were adjusted for height and sex by plotting the probability of the height- and sex-adjusted 
logistic regression model. Associations between the proposed small airway indices (R5-20, X5, AX, 
FEF25-75, LCI, Scond, Sacin, and CALV) were evaluated using height- and sex-adjusted linear 
regression analysis. Two-tailed tests with a significance level of 0.05 were used. The data was 
analyzed with IBM SPSS Statistics Version 23. 
Ethics 
The study was approved by Helsinki University Hospital (ID number: IAS16 ASA04 0116) and 
Helsinki University Hospital Research Ethics Committee (approval number: 390/13/03/03/2015). 
Parents of all participating children provided a written consent, and depending on literacy, the 
children contributed an oral or written consent.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 9 
RESULTS 
Baseline characteristics of the healthy and symptomatic children are presented in Table 2. The 
healthy and symptomatic groups significantly differed only regarding parental smoking. Of the 
symptomatic children, 14 (24%) used continuous and 8 (14%) used intermittent asthma-control 
medication which were ceased ≥4 weeks before the diagnostic lung function measurements. 
Technical success and reproducibility 
All study children performed successful IOS and spirometry measurements. The coherence at 5 Hz 
was ≥0.80 in 64 (83%) IOS measurements, and coherence at 20 Hz was ≥0.80 in all measurements. 
Successful FENO50 measurements were obtained from all except for one child. FENO measurements 
at all flow rates were successfully performed by 19 (100%) healthy controls and 46 (79%) 
symptomatic children, with a median r
2
 of 0.82 (interquartile range (IQR) 0.73-0.91). Of the healthy 
controls, 18 (95%) children and 55 (95%) symptomatic children produced successful MBNW 
measurements with a median coefficient of variation of 5% (IQR 2-10%) for LCI. Successful Scond 
measurements were achieved in 13 (68%) healthy and 40 (69%) symptomatic children, and 
successful Sacin measurements in 14 (74%) healthy and 35 (60%) symptomatic children. Children 
with unsuccessful Scond measurements were significantly younger (p=0.014) than those with 
successful measurements but no other differences in baseline factors or other lung function indices 
were observed in children with unsuccessful Scond or Sacin measurements compared to those with 
successful measurements. 
Differences between patients and controls 
Baseline lung function of the study children are presented in Table 3. All IOS indices as well as 
FEV1/FVC, FEF25-75, and CALV differed between children with recurrent wheezing and healthy 
controls. Regarding children with persistent cough, only IOS indices R5 and R20, and spirometry 
indices FEV1 and FEF25-75 differed from healthy controls. FENO50, JNO, and MBNW indices showed 
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no difference between the symptomatic children and healthy controls. None of the lung function 
indices differed between symptomatic children with or without parental smoking (p>0.05). 
However, separate logistic regression analyses were applied to adjust the parameters for atopic 
status or parental smoking. After adjusting for atopic status, all associations except for the 
difference observed in CALV (p=0.069) between children with recurrent wheezing and healthy 
controls remained significant. After adjusting for parental smoking, the differences in FEV1 
(p=0.107) and FEF25-75 (p=0.088) between children with persistent cough and healthy controls did 
not remain significant. 
Figure 1 presents the height- and sex-adjusted ROC curves illustrating the discriminatory properties 
of IOS, spirometry, and CALV between children with recurrent wheezing and healthy controls. All 
the investigated parameters had an area under the curve (AUC) of >0.70, with R5 and AX providing 
the best discriminatory power (AUC of >0.80). The unadjusted AUCs for the lung function indices 
were as follows: 0.857 (95% confidence interval (CI) 0.748-0.965, p<0.001) for R5, 0.705 (95% CI 
0.563-0.846, p=0.011) for R5-20, 0.777 (95% CI 0.653-0.901, p=0.001) for X5, 0.791 (95% CI 
0.667-0.916, p<0.001) for AX, 0.664 (95% CI 0.523-0.806, p=0.043) for FEV1/FVC, 0.747 (95% 
CI 0.614-0.881, p=0.002) for FEF25-75, and 0.686 (95% CI 0.536-0.836, p=0.028) for CALV.  
Associations with asthma control and exercise-induced bronchoconstriction 
C-ACT was acquired from 51 symptomatic children with a median score of 24 (range 12-27). A C-
ACT score of ≤19 was reported by 11 (31%) of the 36 children with recurrent wheezing and none 
of the 15 children with persistent cough from whom a filled C-ACT questionnaire was received. 
None of the lung function parameters were associated with the C-ACT score. 
Of the symptomatic children, 23 (40%) reported using SABA within the past month, which was 
associated with increased FENO50 (p=0.007) and JNO (p=0.027) but not with the other indices of 
interest. The differences in FENO50 but not in JNO remained significant in the height- and sex-
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adjusted logistic regression analyses (p=0.017 and p=0.056, respectively). Sixteen (28%) children 
required SABA ≤1 time/week, and 7 (12%) ≥2 times/week. Both FENO50 and JNO correlated 
positively with the increasing use of SABA (rs=0.400, p=0.004, and rs=0.377, p=0.017, 
respectively). 
Among the symptomatic children, asthma exacerbations within the past year were reported as 
follows: no exacerbations in 13 (22%), 1-3 exacerbations in 17 (29%), 4-12 exacerbations in 20 
(35%), and >12 exacerbations in 8 (14%) children. Scond, FENO50, JNO, and CALV correlated 
positively with the increasing number of exacerbations (rs=0.340, p=0.032; rs=0.457, p<0.001; 
rs=0.493, p<0.001; and rs=0.337, p=0.022, respectively). Frequent (≥4 per year) exacerbations were 
associated with increased Scond, FENO50 (p=0.003), JNO, and CALV in the symptomatic children 
(Figure 2). These associations remained significant after adjusting for height, sex, and the use of 
asthma-control medications (p<0.05). 
Of the 55 (95%) symptomatic children who performed the exercise challenge test, 20 (36%) 
demonstrated significant EIB. LCI, FENO50 (p=0.007), JNO, and CALV were associated with EIB in 
the symptomatic children (Figure 3). All associations remained significant in the height- and sex-
adjusted logistic regression analysis (p<0.05). 
Associations between proposed small airway indices 
Significant associations were observed between all the IOS indices (R5-20, X5, and AX) and FEF25-
75 (p≤0.001 in each comparison), as well as between Scond and CALV (p=0.035) but not regarding 
other investigated indices.  
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DISCUSSION 
Despite the increasing clinical and research interest towards small airways, their role in pediatric 
asthma is poorly understood. We found subtle but significant differences between 5-10-year-old 
children with mild-to-moderate asthmatic symptoms and healthy controls regarding IOS, 
spirometry, and FENO indices related to small airway function, which suggests that small airway 
dysfunction is present even in mild asthma at this age group. Most of these differences were 
observed only in children with recurrent wheezing but not in those with persistent cough without 
wheezing episodes. None of the MBNW indices showed differences in either of the symptomatic 
subgroups when compared to healthy controls. Among the symptomatic children, Scond and CALV 
were associated with asthma exacerbations within the past year, and LCI and CALV were associated 
with EIB. However, none of the investigated parameters was associated with C-ACT, and only 
bronchial NO measures were related to SABA use within the past month. 
In children, the postulated small airway IOS indices have been found superior to spirometry in 
distinguishing asthmatic symptoms and disease control.
3,5,6
 Results so far have been ambiguous, 
however.
26
 We found differences in R5-20, X5, and AX, which are proposed to reflect small airway 
properties, between children with recurrent wheezing and healthy controls, suggesting that these 
indices might be sensitive in detecting early disease changes of the peripheral airways. Contrary to 
R5 and R20, however, R5-20, X5, and AX were not associated with persistent cough. Although 
persistent troublesome cough is associated with later asthma,
27
 the symptom can result from a wide 
variety of causes,
28
 and is thus less specific for airway obstruction than recurrent wheezing 
episodes.
29
 Therefore, it is possible that this patient subgroup included children with symptoms 
resulting from other etiological causes than asthma, blunting the discriminatory power of the 
investigated indices. Another possible explanation is that this subgroup of children with very mild 
symptoms presented with too subtle or non-existent changes in the peripheral airway region, and 
thus remained undetected with the investigated methods. 
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Based on previous studies, FEF25-75 appears superior to FEV1 in detecting different clinical features 
of pediatric asthma, such as symptoms and disease control.
30,31
 Accordingly, in our study FEF25-75 
was the most sensitive spirometric parameter for distinguishing between healthy and symptomatic 
children, and interestingly, the only proposed small airway index that differed from healthy controls 
in both of the symptomatic subgroups. However, FEF25-75 is not specific to small airway 
obstruction,
13
 and therefore, does not confirm the presence of small airway impairment in these 
subjects. 
Increased ventilation inhomogeneity especially in the conducting airways has been reported in 
asthmatic subjects with well-controlled and mild symptoms when compared to healthy controls.
32-34
 
These changes have predominantly been subtle and within normal ranges, however.
33,35
 Other 
studies have found differences restricted to severe subgroups.
4
 We detected no differences in 
MBNW indices between healthy and symptomatic children. Regarding Sacin and Scond, strict 
technical requirements reduced the number of successful measurements, decreasing the power in 
the statistical analyses, however. In accordance with previous reports,
34,36
 we found a weak 
association between LCI and EIB. In addition, we found an association between Scond and asthma 
exacerbations within the past year. Therefore, MBNW might offer information on the disease 
activity, which is supported by the concurrently observed increases in the FENO indices, especially 
CALV. In line with this, multiple-trigger wheezers have been shown to present with conducting 
airway inhomogeneity.
37
 However, the clinical significance of MBNW in pediatric asthma warrants 
further investigation. 
Increased CALV has predominantly been associated with severe or uncontrolled asthma,
7
 and has 
been observed as less affected in mild disease presentations.
7,9,15,34,38
 Accordingly, we found that of 
the investigated indices, CALV had the strongest associations with asthma exacerbations and EIB, 
indicating that the parameter might be useful in reflecting disease control. Also, in line with the 
proposed small airway IOS indices, CALV differed from healthy controls only in children with 
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recurrent wheezing but not in subjects with isolated cough. FENO measures are, however, influenced 
by several confounding factors,
39
 limiting their diagnostic potential. We also found that after 
adjusting for atopic status, the difference in CALV between healthy and wheezing children did not 
remain significant. 
Studies on the association between small airway dysfunction and asthma control questionnaires are 
conflicting and mainly restricted to adults.
4,26,40
 We found no association between the investigated 
lung function indices and C-ACT scores. However, only 22% of the study subjects reported an 
uncontrolled disease on the C-ACT, which complicates segregation based on the questionnaire. We 
did, however, observe a significant association between asthma exacerbations and Scond and CALV, 
supporting that peripheral airway dysfunction and inflammation might be associated with an 
uncontrolled disease.
6,7
 We also detected an association between EIB and LCI as well as CALV, 
supporting previous reports that small airway dysfunction might be related to airway 
hyperresponsiveness.
31,34,36 
Functional features related to small airway dysfunction are peripheral ventilation heterogeneity, air 
trapping, and premature airway closure. All available techniques measure these changes indirectly, 
and their potential to assess small airways relies on theoretical models which do not elucidate the 
specific lung region or the physiologic determinants they reflect. Studies on the associations 
between different methods are scarce and mainly restricted to older children and adults. In 
accordance with our findings, the postulated small airway IOS indices have been found to correlate 
with mid-expiratory flow spirometric parameters,
41
 whereas CALV seems unrelated to IOS and 
spirometry.
40
 However, CALV has been found to correlate with Scond and Sacin in asthmatic 
children.
34
 We found an association between CALV and Scond but not with Sacin. Also IOS and 
MBNW indices were unrelated, which is in accordance with previous reports in adults that have 
found weak or nonexistent associations between IOS and MBW at baseline.
42
 Although temporal 
variability of airway function is characteristic for asthma, we postulated that 1-14 days in-between 
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the measurements would not have a significant effect on lung function, as no exacerbations or 
interventions occurred between the measurements.
43,44
 
The present study has some limitations regarding the sample size and characteristics. Firstly, as 
power calculations were performed based on AX, it is possible that the study was underpowered for 
some of the other parameters, especially Sacin and Scond, which did not show difference between 
healthy and symptomatic children. Secondly, our patient population consisted of children with 
mild-to-moderate symptoms in the early disease stage. This setting aimed to minimize the 
confounding effects of asthma-control medication and a more generalized airway obstruction. It is, 
however, possible that not all of the symptomatic children present with chronic asthma, especially 
those with isolated cough. Due to challenges in the differential diagnostics of persistent cough,
28
 the 
discriminatory analyses were performed for both symptomatic subgroups separately, and the ROC 
analyses only included children with recurrent wheezing. Thirdly, the control group was relatively 
small and could not be completely matched with symptomatic children with regard to age and 
gender. Therefore, the statistical analyses were adjusted for height and gender. The lung function 
measurements of 19 healthy controls did, however, result in a power that was sufficient to detect 
statistically significant differences in the postulated small airway indices of IOS and spirometry, as 
well as CALV when compared to children with recurrent wheezing. 
In conclusion, we found subtle but significant differences in the proposed small airway IOS, 
spirometry, and FENO indices between children with recurrent wheezing and healthy controls, 
suggesting that early disease changes in the distal airways might be present in young children with 
mild asthmatic symptoms, mainly restricted to recurrent wheezing. In addition, ventilation 
inhomogeneity indices and alveolar inflammation were associated with asthma exacerbations and 
with EIB. The presence of changes in the proposed small airway indices which were not detected 
with FEV1 or FEV1/FVC highlights the additional value of these measures when assessing children 
with asthmatic symptoms. Therefore, they might be used as additional measures in the follow-up of 
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children who present with small airway abnormalities. Further studies are needed to clarify, whether 
children who present with abnormalities in the proposed small airway indices benefit from 
treatment with novel therapies targeting the small airways, and which of the available measures are 
optimal for identifying and following these patients. Of the compared methods, IOS provided the 
best discriminatory properties between healthy and symptomatic children, whereas CALV had the 
strongest associations with asthma exacerbations and EIB. The lack of associations between most of 
the proposed small airway indices suggests that their physiological determinants may be different. 
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FIGURE LEGENDS 
Figure 1. Height- and sex-adjusted receiver operating characteristic curves for the discriminative 
properties of A) respiratory resistance at 5 Hz (R5), difference between respiratory resistance at 5 
and 20 Hz (R5-20), respiratory reactance at 5 Hz (X5), and area under the reactance curve (AX), B) 
forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) and forced expiratory 
flow at 25%-75% of the FVC (FEF25-75), and C) alveolar nitric oxide concentration (CALV) 
between children with recurrent wheezing and healthy controls. AUC, area under the curve; CI, 
confidence interval. 
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Figure 2. Association between asthma exacerbations within the past year and A) conducting airway 
ventilation inhomogeneity (Scond), B) bronchial nitric oxide flux (JNO), and C) alveolar nitric 
oxide concentration (CALV) in the symptomatic children. Statistical analyses were performed using 
Mann-Whitney U test.
 
 
 
Figure 3. Association between exercise challenge test and A) lung clearance index (LCI), B) 
bronchial nitric oxide flux (JNO), and C) alveolar nitric oxide concentration (CALV) in the 
symptomatic children. Statistical analyses were performed using Mann-Whitney U test.
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TABLES 
Table 1. The postulated small airway indices and their hypothetical physiological  
determinants.  
 Unit Physiological determinant 
IOS   
   R5-20  kPa/L/s Resistive properties of the small airways. 
   X5 kPa/L/s Elastic properties of the peripheral lung region. 
   AX kPa/L Integrative measure of the elastic properties of the peripheral lung region. 
Spirometry   
   FEF25-75 L/s Airflow limitation in the small airways. 
FENO    
   CALV ppb Eosinophilic inflammation in the close to or at the alveolar region. 
MBNW    
   LCI – Total ventilation heterogeneity. 
   Scond  1/L Ventilation heterogeneity secondary to small conductive airway dysfunction. 
   Sacin 1/L Ventilation heterogeneity secondary to dysfunction in the alveolar region. 
Abbreviations: AX, area under the reactance curve; CALV, alveolar nitric oxide concentration; 
FEF25-75, forced expiratory flow between 25% and 75% of the forced vital capacity; FENO, 
fractional exhaled nitric oxide; IOS, impulse oscillometry; LCI, lung clearance index; MBNW, 
multiple-breath nitrogen washout test; R5-20, difference between respiratory resistance at 5 and 20 
Hz; Sacin, ventilation inhomogeneity in the acinar structures; Scond, ventilation inhomogeneity in 
the conducting airways; X5, respiratory reactance at 5 Hz.   
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Table 2. Baseline characteristics of the study children. 
Data presented as median (interquartile range) or n (n%). 
a
Birth weight of <2500 grams. 
b
Gestational age of <36 weeks. 
c
Peripheral blood eosinophils of ≥0.4*109/L and ≥4%. 
d
Serum-specific IgE level of ≥0.35 kU/l or skin prick test wheal diameter of ≥3 mm for birch, 
timothy grass, meadow fescue, mugwort, Cladosporium herbarum, cat, dog, horse, cow, or 
Dermatophagoides pteronyssinus. 
*P<0.05 compared to the healthy control group using Chi-squared test.  
 Healthy  
(n=19) 
Recurrent 
wheezing 
(n=42) 
Persistent  
cough 
(n=16) 
All symptomatic 
(n=58) 
Boys (%) 7 (37%) 26 (62%) 10 (63%) 36 (62%) 
Age (years) 7.4 (6.2; 9.3) 6.9 (6.1; 7.8) 7.0 (6.4; 8.4) 7.0 (6.2; 8.2) 
Height (cm) 130 (122; 139) 124 (118; 132) 127 (118; 132) 125 (118; 132) 
Weight (kg) 27 (22; 30) 25 (21; 33) 25 (21; 31) 25 (21; 32) 
Low birth weight
a 0 0 2 (13%) 2 (3%) 
Prematurity
b 0 1 (2%) 2 (13%) 3 (5%) 
Eosinophilia
c
 6 (32%) 24 (57%) 8 (50%) 32 (55%) 
Atopy
d 9 (47%) 30 (71%) 6 (38%) 36 (62%) 
Parental Asthma 6 (32%) 14 (33%) 3 (19%) 17 (29%) 
Parental Smoking 0 14 (33%)* 7 (44%)* 21 (36%)* 
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Table 3. Baseline lung function of the study children. 
 Healthy  
(n=19) 
Recurrent wheezing 
(n=42) 
p* Persistent cough 
(n=16) 
p* 
IOS      
   R5 (kPa/L/s) 0.58 (0.50; 0.69) 0.79 (0.73; 0.91) <0.001 0.79 (0.59; 1.01) 0.016 
   R20 (kPa/L/s) 0.45 (0.41; 0.53) 0.59 (0.53; 0.64) <0.001 0.58 (0.51; 0.71) 0.006 
   R5-20 (kPa/L/s) 0.14 (0.08; 0.21) 0.21 (0.15; 0.29) 0.047 0.15 (0.08; 0.32) 0.260 
   X5 (kPa/L/s) -0.18 (-0.21; -0.16) -0.25 (-0.31; -0.20) 0.013 -0.23 (-0.29; -0.19) 0.073 
   AX (kPa/L) 1.01 (0.49; 1.87) 1.89 (1.48; 2.67) 0.004 1.95 (0.85; 2.95) 0.061 
Spirometry      
   FEV1 (L) 1.67 (1.43; 2.00) 1.54 (1.27; 1.71) 0.160
 
1.45 (1.20; 1.58) 0.031 
   FVC (L) 1.88 (1.66; 2.17) 1.71 (1.40; 2.08) 0.913 1.64 (1.37; 1.92) 0.170 
   FEV1/FVC 0.89 (0.85; 0.92) 0.85 (0.81; 0.91) 0.034 0.86 (0.81; 0.90) 0.216 
   FEF25-75 (L/s) 2.01 (1.63; 2.55) 1.59 (1.39; 1.89) 0.024 1.65 (1.33; 1.91) 0.045 
FENO       
   FENO50 (ppb) 8.50 (4.00; 13.80) 12.90 (7.40; 23.33) 0.073
 
9.30 (4.00; 13.90) 0.596 
   JNO (nL/s) 0.35 (0.17; 0.56) 0.67 (0.32; 0.99) 0.075
 
0.22 (0.13; 0.52) 0.979 
   CALV (ppb) 1.35 (1.16; 2.83) 2.36 (1.54; 4.56) 0.046 1.44 (0.64; 2.70) 0.745 
MBNW       
   FRC (L) 1.44 (1.09; 1.57) 1.13 (1.00; 1.43) 0.514
 
1.18 (1.03; 1.59) 0.612 
   LCI 6.81 (6.41; 7.33) 6.87 (6.52; 7.47) 0.455 6.43 (6.08; 6.55) 0.459 
   Scond (1/L) 0.022 (0.019; 0.037) 0.035 (0.021; 0.042) 0.494 0.026 (0.020; 0.034) 0.969 
   Sacin (1/L) 0.095 (0.043; 0.158) 0.147 (0.049; 0.192) 0.803 0.114 (0.042; 0.192) 0.777 
Data presented as median (interquartile range).  
*P-value compared to healthy control group using height-and sex-adjusted logistic regression 
model. 
Abbreviations: AX, area under the reactance curve; CALV, alveolar nitric oxide concentration; 
FEF25-75, forced expiratory flow between 25% and 75% of the forced vital capacity; FENO, 
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fractional exhaled nitric oxide; FENO50, FENO at 50 ml/s; FEV1, forced expiratory volume in 1 
second; FRC, functional residual capacity; FVC, forced vital capacity; IOS, impulse oscillometry; 
JNO, bronchial nitric oxide flux; LCI, lung clearance index; MBNW, multiple-breath nitrogen 
washout test; R5 and R20, respiratory resistance at 5 and 20 Hz, respectively; R5-20, difference 
between respiratory resistance at 5 and 20 Hz; Sacin, ventilation inhomogeneity in the acinar 
structures; Scond, ventilation inhomogeneity in the conducting airways; X5, respiratory reactance at 
5 Hz. 
 
